C-myc protein, previously unrecognized, spurs extensive nerve growthUsing proteomics techniques to study injured optic nerves, researchers at Boston Children’s Hospital have identified previously…
UT Southwestern’s new operating suite integrates surgical and endovascular techniques in one space
UT Southwestern Medical Center has established a Hybrid Cerebrovascular Operating Suite at Zale Lipshy University Hospital that will combine surgical innovations with advanced imaging capabilities for surgical cases related to stroke and brain aneurysms.
Uncategorized
R-Tech Ueno: Termination of License Agreements for Unoprostone
TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ: 4573) R-Tech Ueno, Ltd. (RTU) today announced it has signed a termination agreement with Sucampo AG (SAG), one of the subsidiaries of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (Sucampo), which terminates,…
Ocular Therapeutix™ to Report First Quarter 2015 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report fi…
New Laboratory Study Shows that NovaBay Pharmaceuticals’ Avenova Completely Inactivates the Bacterial Enzyme that Contributes to Blepharitis and Meibomian Gland Dysfunction
PHOENIX & EMERYVILLE, Calif.–(BUSINESS WIRE)–Phoenix Eye Care and NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY) announced that Dr. Arthur B. Epstein, Director of Clinical Research and head of the Dry Eye – Ocular Surface Disease Center at Phoenix Eye Care, discussed the benefits of NovaBay’s Avenova™ lid & lash cleanser at the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). The poster presentation was held today, May 6, from 11:00 a.m.–12:45 p.m. Centra
NovaBay Pharmaceuticals’ Avenova Brings Significant Improvement to Patients With Blepharitis, New Study Finds
SAN DIEGO & EMERYVILLE, Calif.–(BUSINESS WIRE)–Family Eye Care Optometry and NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY) announced that Guru Sharma O.D. Ph.D., Optometrist at Family Eye Care Optometry and Assistant Professor at Western University of the Health Sciences’ College of Optometry, presented new research documenting the successful use of Avenova™ on patients with blepharitis during the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO). Dr. Sharma’s